Heel pain is a common condition that can be caused by a variety of factors, including plantar fasciitis and Achilles tendinitis. Traditional western medicine treatments for these conditions can be ineffective, with only about 50% of patients experiencing relief from their symptoms. However, Extracorporeal Shockwave Therapy (ESWT) has emerged as a highly effective alternative treatment option.
ESWT is a non-invasive procedure that uses high-energy sound waves to stimulate healing and reduce inflammation in the affected area. This therapy is particularly effective for treating conditions such as plantar fasciitis and Achilles tendinitis. According to Curamedix.com, ESWT has been shown to have an 80% patient satisfaction rate for treating plantar fasciitis.
One of the major benefits of ESWT is that it is a non-invasive treatment option. Unlike traditional western medicine treatments such as cortisone injections or surgery, ESWT does not require any incisions or injections and has minimal downtime.
The benefits of ESWT
Non-invasive
No anesthesia required
No risk of infection
No scarring
No downtime
Over 80% patient satisfaction
Cost effective
Faster, easier healing
Another benefit of ESWT is that it can be used in combination with other treatment options, such as physical therapy and exercise. This can help to maximize the effectiveness of the treatment and promote long-term pain relief.
In conclusion, Extracorporeal Shockwave Therapy (ESWT) is a highly effective treatment option for heel pain caused by conditions such as plantar fasciitis and Achilles tendinitis. With over 80% patient satisfaction rate and minimal downtime, ESWT is an excellent alternative for patients seeking a non-invasive and effective treatment option.
References:
Curamedix, "Extracorporeal Shockwave Therapy (ESWT) for Heel Pain" https://www.curamedix.com/extracorporeal-shockwave-therapy-eswt-heel-pain/
Rompe JD, Nafe B, Furia JP, et al. Extracorporeal shock wave therapy in the treatment of chronic proximal plantar fasciitis: a randomized controlled trial. J Bone Joint Surg Am. 2007;89(5):1010-1017.
Comments